EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Extracellular Vesicles as Liquid Biopsy Biomarkers across the Cancer Journey: From Early Detection to Recurrence

Sagar Rayamajhi iD, Jared Sipes, Ashley L Tetlow, Souvik Saha, Ajay Bansal, Andrew K Godwin iD

Clinical Chemistry · 04.01.2024 · 70 (1) · 206-219

DOI: 10.1093/clinchem/hvad176 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Chemistry, online erschienen am 04.01.2024. Verfasst von Sagar Rayamajhi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, United States. Hauptthemen laut MEDLINE: Neoplasms, Extracellular Vesicles. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIBIB NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Cancer is a dynamic process and thus requires highly informative and reliable biomarkers to help guide patient care. Liquid-based biopsies have emerged as a clinical tool for tracking cancer dynamics. Extracellular vesicles (EVs), lipid bilayer delimited particles secreted by cells, are a new class of liquid-based biomarkers. EVs are rich in selectively sorted biomolecule cargos, which provide a spatiotemporal fingerprint of the cell of origin, including cancer cells. Content This review summarizes the performance characteristics of EV-based biomarkers at different stages of cancer progression, from early malignancy to recurrence, while emphasizing their potential as diagnostic, prognostic, and screening biomarkers. We discuss the characteristics of effective biomarkers, consider challenges associated with the EV biomarker field, and report guidelines based on the biomarker discovery pipeline. Summary Basic science and clinical trial studies have shown the potential of EVs as precision-based biomarkers for tracking cancer status, with promising applications for diagnosing disease, predicting response to therapy, and tracking disease burden. The multi-analyte cargos of EVs enhance the performance characteristics of biomarkers. Recent technological advances in ultrasensitive detection of EVs have shown promise with high specificity and sensitivity to differentiate early-cancer cases vs healthy individuals, potentially outperforming current gold-standard imaging-based cancer diagnosis. Ultimately, clinical translation will be dictated by how these new EV biomarker-based platforms perform in larger sample cohorts. Applying ultrasensitive, scalable, and reproducible EV detection platforms with better design considerations based upon the biomarker discovery pipeline should guide the field towards clinically useful liquid biopsy biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsExtracellular VesiclesHumansEarly Detection of CancerLiquid BiopsyBiomarkers

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, United States.
  • Division of Gastroenterology and Hepatology, University of Kansas Health System, Kansas City, KS, United States.
  • The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, United States.
  • Division of Genomic Diagnostics, University of Kansas Health System, Kansas City, KS, United States.
  • Kansas Institute for Precision Medicine, University of Kansas Medical Center, Kansas City, KS, United States.

ORCID-Profile: Sagar Rayamajhi, Andrew K Godwin

Förderung

  • NIGMS NIH HHS
  • NCI NIH HHS
  • NIBIB NIH HHS

Zitieren

APA

Rayamajhi, S., Sipes, J., Tetlow, A. L., Saha, S., Bansal, A., & Godwin, A. K. (2024). Extracellular Vesicles as Liquid Biopsy Biomarkers across the Cancer Journey: From Early Detection to Recurrence. Clinical Chemistry, 70(1), 206-219. https://doi.org/10.1093/clinchem/hvad176

Vancouver

Rayamajhi S, Sipes J, Tetlow AL, Saha S, Bansal A, Godwin AK. Extracellular Vesicles as Liquid Biopsy Biomarkers across the Cancer Journey: From Early Detection to Recurrence. Clinical Chemistry. 2024;70(1):206-219. doi:10.1093/clinchem/hvad176

BibTeX
@article{Rayamajhi2024,
  author = {Rayamajhi, Sagar and Sipes, Jared and Tetlow, Ashley L and Saha, Souvik and Bansal, Ajay and Godwin, Andrew K},
  title = {Extracellular Vesicles as Liquid Biopsy Biomarkers across the Cancer Journey: From Early Detection to Recurrence},
  journal = {Clinical Chemistry},
  year = {2024},
  volume = {70},
  number = {1},
  pages = {206--219},
  doi = {10.1093/clinchem/hvad176}
}
Kostenlos starten →